Can-Fite BioPharma Ltd. (CANF) — Dilution Risk Analysis

Current Snapshot

Can-Fite BioPharma Ltd. (CANF) has a DilutionWatch score of 82/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
2,618,425 Source

Dilution Risk Score

Score: 82/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 3 5, 424B3 1, EFFECT 3, F-3 1.

FormFiledAccession
3 2026-04-06 0001213900-26-040473
424B3 2026-04-03 0001213900-26-040022
EFFECT 2026-04-03 9999999995-26-001089
F-3 2026-03-31 0001213900-26-036631
EFFECT 2026-03-31 9999999995-26-001005
EFFECT 2026-03-31 9999999995-26-001009
3 2026-03-18 0001213900-26-029799
3 2026-03-18 0001213900-26-029802
3 2026-03-18 0001213900-26-029809
3 2026-03-18 0001213900-26-029813

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 7 months Source
Three-year share count growth 119.38% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 82/10) Source
Cash Runway
7 months Source
Share Count Growth (3-Year)
119.38% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.